Login
INTUITIVE SURGICAL INC logo

INTUITIVE SURGICAL INC

intuitive.com

What Do They Do?

Sells surgical instruments and accessories for robotic-assisted surgery, along with robotic surgical and lung-biopsy systems and related services, to hospitals and healthcare facilities.

How Do They Make Money?

Hospitals and other customers buy instruments, systems, and service. Instrument sales are generally paid at shipment or delivery; direct system sales are paid after delivery acceptance or installation, while systems sold through distributors are paid at shipment; service contracts are billed upfront, while time-and-material work is billed when performed.

revenue
SegmentShareRevenue
Instruments and accessories
Sold outright

60%
FY2022: 57%
Systems
Sold outright

25%
FY2022: 27%
Service
16%
FY2022: 16%

Who Are Their Customers?

Hospitals and healthcare facilities buy through direct sales teams in many markets; distributors handle sales in the remaining international markets and some U.S., China, and Japan sales. China sales also run through majority-owned joint ventures.

Do Revenues Turn Into Profits?

Yes. It kept 28 cents of every revenue dollar as net income in FY2025 and turned 25 cents into free cash flow.

Operating income, FY2025
29% of revenue
▲ +25% vs FY2024 ($2.3B, 28%)
Net income, FY2025
28% of revenue
▲ +23% vs FY2024 ($2.3B, 28%)
Free cash flow, FY2025
25% of revenue
▲ +91% vs FY2024 ($1.3B, 16%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +22%
vs $2.5B in Q3 FY2025
Net income
▼ −26%
vs $704.4M in Q3 FY2025
Instruments and accessories share of revenue vs 60.6% in Q3 FY2025
  • Jul 16, 2026 Company issues full-year procedure-growth outlook It expects worldwide da Vinci procedure growth of approximately 13.5% to 15.5%.
  • Mar 2, 2026 Acquires da Vinci and Ion distribution business The acquired business expands direct operations in Italy, Spain, Portugal, Malta, San Marino, and associated territories.

Growing. Revenue grew 76% in 4 years, from $5.7B in FY2021 to $10.1B in FY2025, about 15% a year.

New da Vinci system generation The latest report adds a new generation of da Vinci surgical system, with force feedback and digital features, beyond the models described in the older report.

Expanded energy equipment The latest report adds a generator for cutting, sealing, and coagulating tissue, alongside the upgrade generator described in the older report.

Revenue over time
Instruments and accessories Systems Service
$20B$10B$0

Who Do They Compete With?

Competes with Johnson & Johnson, Medtronic, Beijing Surgerii Robotics, CMR Surgical, Distalmotion, Harbin Sizhe Rui Intelligent Medical Equipment, Karl Storz, Medicaroid, meerecompany, Noah Medical, Shandong Weigao Group Medical Polymer, Shanghai Microport Medbot (Group), Shenzhen Edge Medical, and SS Innovations International

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support